We have previously reported the activation of Src by mercuric chloride based on the sulfhydryl modi®cation. To evaluate the signi®cance of cysteine residues in v-Src, we replaced each cysteine to alanine by oligonucleotidedirected mutagenesis and examined its eect on cell transformation. Of ten cysteine residues scattered over vSrc, four cysteines clustered in kinase domain, Cys483, Cys487, Cys496 and Cys498, were important for protein stability and cell transformation, whereas those in SH2 domain were dispensable. A single mutation in Cys498 yielded suppression of kinase activity and a temperaturesensitivity in anchorage independent growth. Double mutation either in Cys483/Cys487 or in Cys496/ Cys498 yielded clear temperature-sensitivity in cell transformation and in stability of Src protein. Instability of Src protein was magni®ed by quadruple mutation in the cysteines, which decreased the half-life of Src to be less than one quarter of that of wild-type. In addition, both Cys483/Cyr487 and Cys496/Cys498 kinases became resistant to in vitro inactivation by herbimycin A, which directly inactivates v-Src in addition to its eect on HSP90. Taken together, our results strongly suggest that the cysteine clustered motif of v-Src are critical for protein stability, cell transformation and in vitro inactivation by herbimycin A. Oncogene (2000) 19, 273 ± 279.
Introduction
The oncogene product of Rouse sarcoma virus (RSV), the v-Src kinase, is a membrane-bound tyrosine protein kinase (Jove and Hanafusa, 1987) . Src has structural features required for the transforming activity. The Nterminus of v-Src, especially Glycine at position 2, is essential for its myristylation, membrane-binding and for the transforming activity Kamps et al., 1985) . The region following the membranebinding domain contains the src homology 3 (SH3) and the src homology 2 (SH2) domains, both of which are also important for cell transformation (Cross et al., 1985) . SH2 and SH3 speci®cally bind to phosphotyrosine residues and short proline-rich peptide motifs, respectively, and thereby regulate substrate speci®city (Pawson, 1995) . The cellular counterpart of v-src, c-src, encodes a tyrosine kinase but inactive in transformation (Iba et al., 1984) . The Carboxyl terminal tyrosine at position 527 (Tyr527) that is unique to c-Src kinase regulates kinase activity. Point mutation at Tyr527 converted c-Src to be active in kinase and highly oncogenic (Cartwright et al., 1987; Kmiecik and Shalloway, 1987; Piwnica-Worms et al., 1987) . Consistently, targeted disruption of CSK (Nada et al., 1991) that phosphorylates Tyr527 caused activation of c-Src (Imamoto and Soriano, 1993 ). It appears that intramolecular interaction between SH2 and phosphorylated Tyr527 together with SH3 and the linker region down-regulates the c-Src kinase (Superti-Furga et al., 1993; Xu et al., 1997; Sicheri et al., 1997) .
Evidence accumulated suggested that Src kinase activity is regulated by a mechanism that is based on the redox-linked protein modi®cation and independent of Tyr527-phosphorylation (Pu et al., 1996) . SHreagents such as N-[p-(2-benzimidazolyl)phenyl] maleimide and N-(9-acridinyl)maleimide could inactivate v-Src kinase (Fukazawa et al., 1990) . Herbimycin A, a benzenoid ansamycin antibiotic, was shown to inactivate the v-Src kinase in vitro (Uehara et al., 1986) . Herbimycin A bound directly to the kinase domain of v-Src (Fukazawa et al., 1994) and sulfhydryl compounds such as dithiothreitol and cysteine abolished the eect of herbimycin A, indicating that sulfhydryl groups in the kinase domain of v-Src are involved in the direct inactivation (Uehara et al., 1989a) . In contrast, we showed that mercuric chloride could directly activate Src in vitro in a Tyr527-independent manner (Pu et al., 1996) . Since mercuric ions react with sulfhydryl groups of proteins in an exceptionally high association constant (Stricks and Kolto, 1953; Simpson, 1961) and N-acetylcysteine abolished its eect on Src, mercuric ions may preferentially bind to sulfhydryl groups of Src. In concert with our ®nding, oxidative stress was shown to activate Ltk by the formation of disul®de-linked Ltk multimer (Bauskin et al., 1991) .
These observations suggest that cysteine residues of Src play an important role in the function of Src. It is, however, unclear whether all of cysteines that scatter over the Src molecule are equally functional. As a ®rst step to assess the signi®cance of each cysteine residue, we constructed a series of v-Src mutants, whose cysteines were replaced by alanines through sitedirected mutagenesis. We examined the transforming activity and the in vitro inhibitory eect of herbimycin A on these Src kinases. Here we show that, among ten cysteine residues in v-Src, Cys483, Cys487, Cys496 and Cys498, clustered in the kinase domain of v-Src, are important for the protein stability, cell transformation and for the direct inactivation by herbimycin A. In contrast, other cysteine residues including those in the SH2 domain are dispensable for cell transformation.
Results
Eect of point mutation of cysteine residues on transforming activity of v-src Of ten cysteine residues that scattered over the v-Src protein, three of them, Cys185, Cys238 and Cys245, are located in the SH2 domain two, Cys277 and Cys400, are in the N-terminal part of catalytic domain, four, Cys483, Cys487, Cys496 and Cys498, form a cluster at the bottom of catalytic domain, and one, Cys520, is in the C-terminal end. Among these cysteines, two in the SH2 domain (Cys238 and Cys245) and three in kinase domain (Cys400, Cys487 and Cys498) are highly conserved among src family kinases ( Figure 1) .
To assess the role of each cysteine of v-Src, a series of mutants were constructed to replace each of cysteine residues to alanines by site-directed mutagenesis. In this experiment, substitution from cysteine to alanine was chosen. These mutant v-src genes which have a single point mutation in one of the cysteines were named C1A (mutated in Cys185), C2A (Cys238), C3A (Cys245), C4A (Cys277), C5A (Cys400), C6A (Cys483), C7A (Cys487), C8A (Cys496), C9A (Cys498) and C10A (Cys520). These mutant genes were ligated into pBabe-puro vector, recon®rmed the mutations by sequencing and transfected into a rat cell line, 3Y1. 3Y1 and 3Y1 transformed with wild-type RSV (SR3Y1) were used as a control. Most of the colonies, selected by puromycin-resistance, showed the clear characteristics of transformed cells such as round, refractile morphology (data not shown). Each of mutated v-src genes produced similar number of colonies as wild-type v-src and no clear dierence was observed among these mutant-transfected clones in their morphology and growth. Several colonies of each mutant were selected and following results were obtained with representative clones of the mutants.
Src protein expression and tyrosine phosphorylation of cellular proteins in these mutant-transfected clones were examined by immunoblotting with anti-Src and anti-phosphotyrosine antibodies (Figure 2 ). All mutant cell lines expressed v-Src protein to the levels similar to SR3Y1. The levels and pro®les of tyrosine phosphorylation in these clones were also similar to those of SR3Y1.
In contrast to the transforming activity of the mutants, one of the mutants, C9A, substituted at Cys498, showed dierence in the kinase activity. As shown in Figure 2 , kinase activity of C9A Src was much reduced to the level similar to that of c-Src, although it clearly transformed cells and activated tyrosine phosphorylation of cellular proteins. On the other hand, other mutants showed high activities comparable to that of wild-type v-Src. We carefully conducted the experiment to avoid possible inactivation of mutant Src kinase during immunoprecipitation and in vitro kinase assay; but all the results obtained showed the low activity of C9A kinase. These results suggest that kinase activity of C9A Src may be very labile in vitro.
C9A v-Src is a temperature sensitive mutant Matsumura et al. (1989) reported that introduction of cysteine residues stabilized T4 lysozyme to be resistant to heat denaturation. Together with their ®ndings, previous reports suggest that some of the temperature sensitive (ts) mutants of v-Src kinase are labile in vitro (Jove et al., 1986; Maroney et al., 1992) as C9A. Given these ®ndings, we investigated whether C9A Src had its phenotype. As shown in Figure 3a , cells expressing C9A Src, incubated at the non-permissive temperature (39.58C), showed¯atten morphology, although it still retained partially fusiform morphology and decreased cell-cell adhesion when compared with parental 3Y1. In addition, C9A cells at 39.58C could grow in higher density than parental 3Y1 (data not shown). However, we found that C9A cells completely lost anchorage independent growth in soft agar at 39.58C ( Figure 3b ). On the other hand, C9A cells incubated at the permissive temperature (348C) displayed anchorage independent growth and clear morphological transformation to the levels identical to those of SR3Y1.
We examined tyrosine phosphorylation of cellular proteins and kinase activity of C9A mutant at both temperatures. As shown in Figure 4a , C9A cells maintained at 39.58C expressed Src protein to the level similar to those at 348C and SR3Y1. Interestingly, most of the tyrosine phosphorylated proteins in C9A cells remained phosphorylated at 39.58C, but some of them including p36 showed weaker levels of phosphorlyation. These results suggest that C9A kinase at 39.58C may be partially inactivated so that caused a dierence in the spectrum of its substrate proteins when compared with those at 348C. In contrast, in vitro kinase activities of C9A mutant were decreased by similar levels at both temperatures. We found, however, C9A Src was more labile to in vitro heat inactivation than the wild-type v-Src (Figure 4c,d) .
In contrast to C9A mutant, other mutants speci®cally those which have single mutation in SH2 region, C2A and C3A, had no temperature sensitive phenotype (Figures 3 and 4) . Cells transfected with these SH2 region mutants were transformed well and similar levels and pro®les of tyrosine phosphorylation were observed both at 39.58C and 348C (Figure 4 ). Around Cys498, totally four cysteine residues are clustered ( Figure 1 ). Among these cysteines, ®rst two residues, Cys483 and Cys487, and latter two residues, Cys496 and Cys498, are closely located to each other. Since these paired cysteines might compensate their function each other because of their close localization, we introduced double mutations in these clustered cysteines. Two types of mutants were constructed. One mutant Src, C67A, has substitution of cysteines at positions 483 and 487 to alanines in pair. Another mutant, C89A, has substitution of cysteines at positions 496 and 498. When C67A and C89A mutants were transfected into 3Y1, both of them had transforming activity but cells showed partly¯attened fusiform morphology at 378C which was not observed with C9A cells cultured at 378C (data not shown). Several cell clones transfected with C67A or C89A mutants were isolated. It should be noted here that we showed results with one representative clone of each mutant in the following experiments, but con®rmed that data with more than two cell clones. When these clones were cultured at 348C, all clones transformed well with round-up morphology and grew well in soft agar to the levels similar to those of wild-type v-srctransformed cells (Figure 5a ). In contrast, these cells lost the anchorage independent growth in soft agar, and their morphology was reverted to a normal type when incubated at 39.58C for 2 days. We found that reversion of cell morphology in these mutanttransfected cells at the non-permissive temperature was more prominent than that of C9A mutant. However morphological reversion took longer time than those of classical ts mutants such as NY68 and NY72, both of which take only a few hours for the reversion of morphology.
Tyrosine phosphorylation of cellular proteins in C67A and C89A cells was examined by immunoblotting with anti-phosphotyrosine antibody (Figure 5b ). At 348C, both the pro®les and the levels of tyrosine phosphorylation in these cells were essentially similar to those in SR3Y1. However, when cells were incubated at 39.58C for 2 days, tyrosine phosphorylation of cellular proteins in these C67A and C89A cells were dramatically reduced. Concomitantly, we found that steady state levels of C67A and C89A Src proteins at 39.58C were decreased to 22 and 28% of those at 348C, respectively.
To determine the speci®c activities of the mutant Src, similar amounts of Src kinases were immunoprecipitated from cells incubated at either 348C or 39.58C. Immunoprecipitated Src kinases were tested for in vitro kinase assay (Figure 5c ). Compared with wild-type vSrc, kinase activities of these double mutants were dramatically decreased but showed no dierence depending on the incubation temperatures.
C67A and C89A Src are thermolabile
Since steady state levels of C67A and C89A Src proteins were signi®cantly reduced at the nonpermissive temperature, half-lives of mutant Src proteins were examined by pulse-chase labeling and subsequent immunoprecipitation. C67A and C89A cells were labeled with 35 S-methionine for 30 min and subsequently chased for the indicated times at 348C and 39.58C. Src protein was immunoprecipitated with antibody as described in Materials and methods. As shown in Figure 6a , both of mutant Src proteins had decreased half lives of approximately 4 h at 39.58C, while no reduction of half lives were observed at 348C. In contrast, wild-type v-Src had half life of around 8 h at both temperatures.
Mutant v-Src with quadruple cysteine replacement is most labile
To evaluate further the importance of the clustered cysteine residues on the stability of the protein, we next constructed a mutant v-Src, in which all of four clustered cysteines, Cys483, Cys487, Cys496 and Cys498, were replaced to alanine. When this C6-9A mutant gene was transfected into 3Y1, no transformed colonies appeared after 2 weeks of incubation. Therefore, we speculated that degradation of v-Src occurred too fast to transform cells. To con®rm our hypothesis, transient expression of the mutant gene in COS7 cells was examined. As shown in Figure 6b and d, with same amount of DNA, steady state expression of C6-9A Src was only 13% of wild-type v-Src, whereas that of C67A mutant in COS7 was 73% of wild-type v-Src. To assess the half-life of the mutant Src, pulse-chase experiment was undergone with COS7 cells. Two days after the transfection, C6-9A cells were labeled with 35 S-methionine for 30 min and chased for indicated hours. As shown in Figure 6c and e, half-life of C6-9A Src was drastically reduced to be approximately 2 h at 378C, which was only oneforth of wild-type v-Src.
C67A and C89A mutants are resistant to herbimycin A in vitro
Herbimycin A, a benzenoid ansamycin antibiotic, was shown to inactivate the v-Src kinase in vitro (Uehara et al., 1986) by direct binding to the kinase domain of vSrc (Fukazawa et al., 1994) . Sulfhydryl compounds such as dithiothreitol and cysteine abolished the eect of herbimycin A (Uehara et al., 1989a) . Given these ®ndings, we examined the eect of herbimycin A on the mutants. In this study, we used casein instead of enolase as an exogenous substrate, since enolase requires acid-treatment that partially inhibits the effect of herbimycin A (Senga and Hamagushi, unpublished data). Immunoprecipitated C6A, C7A, C8A, C9A and wild-type v-Src were incubated in the presence or absence of herbimycin A (100 mg/ml) for 20 min at 308C in kinase buer, and, subsequently, tested for in vitro kinase assay. As shown in Figure 7a , these single mutated Src kinases were similarly sensitive to herbimycin A as that of wild-type v-Src. Although C9A mutant showed low level of kinase activity, it showed clear suppression by herbimycin A-treatment when over-exposed as Figure 7b . In contrast to these single mutated Src kinases, both types of doubly mutated Src, C67A and C89A, showed clear resistance to herbimycin A-treatment (Figure 7c ). These results suggest that clustered cysteines in kinase domain of vSrc are required, in pair, for the direct inhibition of kinase activity by herbimycin A. We also tried to test the eect of herbimycin A on quadruply mutated Src, C6-9A. However, we could not get clear results because of its instability.
Discussion
In this report, we showed evidence that, among ten cysteine residues in v-Src, four clustered cysteines in the C-terminal portion of kinase domain, i.e. Cys483, Cys487, Cys496 and Cys498, in particular Cys498, are important for the enzymatic activity and thermostability of v-Src kinase. In contrast, cysteines in SH2 domain were dispensable for the catalytic activity of kinase and for cell transformation, although two of them are highly conserved among Src family tyrosine kinases. These cysteine mutations in kinase domain exhibited two modes of eect on the v-Src function, i.e. suppression of the catalytic activity and thermoinstability of the protein. We found that Cys498 mutation alone was critical and sucient for the suppression of in vitro kinase activity and for the temperature-sensitive phenotype in anchorage indepen- v-Src cysteines critical for transformation T Senga et al dent growth but did not cause temperature-sensitive degradation of kinase. In contrast, accumulation of mutations in clustered cysteine residues facilitated the thermolabile phenotype. C6-9A mutant in which all four cysteines were replaced to alanines had only 2 h of half-life at 378C, whereas wild type v-Src had 8 h. These results suggest that suppression of catalytic activity and thermoinstability of v-Src delivered by these cysteine mutations were closely associated each other but partly dissociated in terms of critical cysteines.
C9A cells showed ts phenotype in anchorage independent growth, yet many cellular proteins remained phosphorylated at the nonpermissive temperature (Figures 3 and 4) . We found, however, that some of the substrate proteins including p36 showed weaker phosphorylation at 39.58C. These results suggest that C9A mutations may aect on the substrate speci®city, directly or indirectly, in a temperature-dependent manner. Further characterization of C9A mutant is currently undergone.
Of the four cysteines in the kinase domain, Cys487 and Cys498 are highly conserved among Src family kinases. Veillette et al. (1993) also investigated the role of these conserved cysteines in the lymphocyte-speci®c tyrosine protein kinase Lck. They reported that mutation of either of these two cysteines abolished the enzymatic function of Lck. In contrast to Lck, mutation in Cys487, but not in Cys498, did not abolish the catalytic function of v-Src. On the other hand, mutation in Cys498 (C9A) did not simply inhibit cell transformation, but yielded a temperature-sensitive phenotype in anchorage independent growth. V-Src has two additional cysteines, Cys483 and Cys496, suggesting that these additional cysteines may compensate the function of Cys487 and Cys498. Indeed, we found that v-Src became thermolabile along with the accumulation of mutation in clustered cysteine residues.
Our results showed that these clustered cysteines were required in pair for the direct inhibition of v-Src kinase by herbimycin A in vitro. The double mutations, but not the single mutations, yielded the resistance to herbimycin, suggesting that the drug requires paired cysteines or that neighboring cysteines can compensate the function. We found, however, that herbimycin Atreatment of cells transformed with these double mutants reverted their morphology to a normal one (data not shown). Several lines of evidence suggest that the suppression of v-Src kinase alone cannot explain the morphological reversion of transformed cells by the drug and that some additional factors other than kinase inhibition should be taken into consideration. First, the drug dose eective for the complete reversion of cell morphology (0.5 ± 1.0 mg/ml) is far lower than its in vitro IC 50 values (100 mg/ml) (Uehara et al., 19989b) . Second, the v-Src kinase activity of herbimycin A-treated cells remained as high as 50% of the control level, which is much higher than those of transforming mutants of c-Src (Hamaguchi et al., 1993a) . Third, under the conditions in which herbimycin A fully reverses the cell morphology, many cellular proteins remained phosphorylated, suggesting that vSrc is still enzymatically active (Hamaguchi et al., 1993a) . Fourth, herbimycin A treatment of cells clearly inhibited the association of phosphatidylinositol (PI) 3 kinase with v-Src (Hamaguchi et al., 1993a) . Fifth, herbimycin A inhibited the complex formation of v-Src with HSP90 (Whitesell et al., 1994) which seemed to govern v-Src activity in yeast-system (Xu and Lindquist, 1993) . Thus, herbimycin A appears to have multifarious eects on cell transformation by v-Src. Consistently however, our results suggest that clustered cysteines in the kinase domain are required for the direct inhibition of kinase activity by herbimycin A. It should be noted that treatment of cells with herbimycin A accelerated the decay of v-Src (Uehara et al., 1989b; Hamaguchi et al., 1993a) . Half-life of v-Src in treated cells was approximately one quarter of that in untreated cells (Hamaguchi et al., 1993a) . As shown in Figure 6c , quadruple mutation in cysteines also dramatically accelerated the degradation of v-Src and half-life of C6-9A Src appears to be less than 2 h. Although the cysteine residues directly modi®ed by herbimycin A is yet unclear, our results suggest that any compounds that can modify these cysteines might speci®cally regulate v-Src kinase activity. These cysteines clustered in kinase domain might work as a regulatory domain for the cysteine-based regulation of Src kinase.
According to the crystal model of c-Src (Xu et al., 1997) , these clustered cysteine residues are located at the bottom part of the kinase domain. Cys496 and Cys498 are located in the end of a-helix, while Cys483 and Cys487 are not. We tried to estimate the formation of S-S bond among these cysteine residues by RaMol program, and the model obtained suggested that Cys483 and Cys487 have a potential to form S-S bond, while 496 and Cys498 are not, although these latter pair closely located each other. Further structural studies with puri®ed Src are currently undergone to investigate the structural change of v-Src kinase mediated by the modi®cation of cysteine residues.
Materials and methods

Cells and antibodies
3Y1 and RSV-transformed 3Y1, SR-3Y1, were maintained as described previously (Hamaguchi and Hanafusa, 1987; Hamaguchi et al., 1988) .
Anti-Src monoclonal antibody, mAB327, was kindly provided by Dr JS Brugge (Harvard Medical School; Lipsich et al., 1983) . Anti-phosphotyrosine monoclonal antibody, PY20, was purchased from Transduction Lab.
Site-directed mutagenesis and transfection
Cysteine residues in v-src were substituted to alanines by PCR as previously reported (Mikaelian and Sergean, 1992) . Mutated fragments were ligated into pBluescript vector, sequenced and ligated into v-src gene. Mutated v-src were then ligated into pBabe-puro vector and recon®rmed the substitution by sequencing. Each mutated v-src was transfected to 3Y1 cells using LipofectACE 2 (Gibco ± BRL) according to the manufacture's protocol. Cell clones were selected by puromycine and isolated.
In vitro kinase assay and immunoblotting
In vitro kinase assay was performed as described (Hamaguchi and Hanafusa, 1987; Hamaguchi et al., 1993b) . In brief, cells were lysed with RIPA buer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 1% sodium v-Src cysteines critical for transformation T Senga et al deoxycholate, 0.1% SDS) and immunoprecipitated with antiSrc (mAb327). Immunoprecipitates were washed and incubated with kinase buer (10 mM Tris-HCl pH 7.4, 5 mM MgCl 2 ) containing [g 32 P]ATP (370 kBq) (NEN, Wilmington, DE, USA) and 1.5 mg acid-treated enolase (Sigma) as an exogenous substrate. To treat the v-Src with herbimycin A, immunoprecipitates were incubated with kinase buer containing herbimycin A (100 mg/ml) for 20 min at 308C before the kinase assay. One mg casein was used instead of enolase. The kinase reaction was carried out for 10 min at 308C, subjected to electrophoresis and analysed by BAS 2000 system. Immunoblotting was performed as described (Hamaguchi et al., 1993a) .
Pulse-chase experiment
Pulse-chase labeling of v-Src was performed as described previously (Hamaguchi et al., 1993b) . Brie¯y, cells were incubated for 30 min with medium containing 0.5 mCi of [ 35 S]methionine (41000 Ci (37.0TBq)/mmol; NEN). After washing cells, cells were incubated with medium containing 1 mM methionine, chased for indicated times and harvested.
Pulse chase of mutant Src with COS7 cells was performed as the following. Five mg of DNA was transfected to COS7 cells with DEAE dextran. Next day, cells were split and, at 2 days after the transfection, cells were labeled.
